Clinical Trial

Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) System in Paroxysmal and Persistent Atrial Fibrillation

Study acronym: NEXT PULSE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The NEXT PULSE study is a pre-market, prospective, multi-center, non-randomized, interventional clinical study. Adult subjects with symptomatic paroxysmal or persistent AF who provided consent will be enrolled and treated with the PulseSelect PFA System.
Trial Details
NCT Number NCT07575828
Lead Sponsor Medtronic Cardiac Ablation Solutions
Conditions Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fibrillation
Enrollment 320 participants
Start Date 2026-08
Primary Completion 2028-08 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-08